Study Follows RITA's Recent FDA Clearance for Bone Tumors

North America by Deloitte & Touche

2002 Global Health Care Conference in New York City

U.S. Sales Up 64 Percent Over Year-Earlier Period; Loss Narrows to $0.18

For Relief of Pain From Bone Tumors
</p><p>
Study Led by Mayo Clinic Showed Patients Experienced Significant and Lasting
</p><p>
Reductions in Debilitating Pain
</p>

RITA Comments on Impact of Temporary Infusion Pump Supply Issue MOUNTAIN VIEW, Calif., Oct. 18 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that it was experiencing a supply disruption with an accessory infusion pump used with its StarBurst™ XLi

RITA Medical Systems Announces Date for Third Quarter, Nine-Month Results Release and Conference Call MOUNTAIN VIEW, Calif., Oct. 18 -- RITA Medical Systems, Inc. (Nasdaq: RITA), a medical device company that develops, manufactures and markets minimally invasive products to treat patients with

Dramatically Increases Liver Cancer Survival Rates
</p><p>
Procedure Provides New Hope for Patients
</p><p>
With Unresectable Liver Cancer and Colorectal Cancer
</p>

Are Rejected in Interference Proceeding

RITA Medical Systems Liver Cancer Survival Data To Be Presented at ACS MOUNTAIN VIEW, Calif., Sept. 9 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that survival data from a multi-center retrospective study on the use of its proprietary radiofrequency (RF)

RITA Medical Systems Receives Approval to Market Its Second Generation Products in Japan MOUNTAIN VIEW, Calif., July 30 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that it has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW)

RITA Medical Systems Announces Second Quarter, Six-Month Results; U.S. Sales Up 100 Percent Over Year-Earlier Period MOUNTAIN VIEW, Calif., July 25 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced results for its second quarter and six months ended June 30, 2002.

RITA Medical Systems Announces Date For Second Quarter, Six-Month Results Release and Conference Call RITA Medical Systems Announces Date For Second Quarter, Six-Month Results Release and Conference Call MOUNTAIN VIEW, Calif., July 22 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc.

RITA Medical Systems Added to Russell 2000(R) Index RITA Medical Systems Added to Russell 2000(R) Index MOUNTAIN VIEW, Calif., July 15 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that it has been added to the list of companies in the Russell 2000 ® Index

RITA Medical Systems Says Recent Boston Scientific Patent Lawsuit Is Without Merit RITA Medical Systems Says Recent Boston Scientific Patent Lawsuit Is Without Merit MOUNTAIN VIEW, Calif., July 12 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that a patent

95% of Patients Had a Significant Reduction in Pain

Data Show RITA Medical Systems Radiofrequency Technology Effective In Treating Uterine Fibroids MOUNTAIN VIEW, Calif., May 8 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that the results of a retrospective case series on the use of its proprietary

U.S. Sales Up 101 Percent Over Year-Earlier Period;
21 Percent Over 2001 Fourth Quarter

RITA Medical Systems Appoints Jay Watkins To Board of Directors RITA Medical Systems Appoints Jay Watkins To Board of Directors MOUNTAIN VIEW, Calif., April 18 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that it has appointed former senior Guidant Corporation

RITA Medical Systems Announces First Quarter Results Release and Conference Call Date MOUNTAIN VIEW, Calif., April 17 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a medical device company that develops, manufactures and markets minimally invasive products to treat patients